LENZ - LENZ Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LENZ is currently covered by 2 analysts with an average price target of $54.95. This is a potential upside of $14.95 (37.38%) from yesterday's end of day stock price of $40.

LENZ Therapeutics's activity chart (see below) currently has 0 price targets and 5 ratings on display. The stock rating distribution of LENZ is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 83.33% with an average time for these price targets to be met of 236.5 days.

Highest price target for LENZ is $48, Lowest price target is $48, average price target is $42.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 28-Jul-2025. First documented stock forecast 27-Mar-2024.

Best performing analysts who are covering LENZ - LENZ Therapeutics:

Matthew Caufield Joseph Catanzaro

Currently out of the existing stock ratings of LENZ, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$48

$8 (20.00%)

$38

27 days ago
(28-Jul-2025)

2/3 (66.67%)

$16.49 (52.33%)

321

Buy

$36

$-4 (-10.00%)

$28

1 years 9 days ago
(15-Aug-2024)

2/2 (100%)

$13.4 (59.29%)

152

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LENZ (LENZ Therapeutics) average time for price targets to be met?

On average it took 236.5 days on average for the stock forecasts to be realized with a an average price target met ratio 83.33

Which analyst has the current highest performing score on LENZ (LENZ Therapeutics) with a proven track record?

MATTHEW CAUFIELD

Which analyst has the current lower performing score on LENZ (LENZ Therapeutics) with a proven track record?

JOSEPH CATANZARO

Which analyst has the most public recommendations on LENZ (LENZ Therapeutics)?

Matthew Caufield has 11 price targets and 8 ratings on LENZ

Which analyst is the currently most bullish on LENZ (LENZ Therapeutics)?

Matthew Caufield with highest potential upside - $8

Which analyst is the currently most reserved on LENZ (LENZ Therapeutics)?

Joseph Catanzaro with lowest potential downside - -$4

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?